Skip Navigation

Clinical Resources

  • Two doctors and a nurse consulting with each other

    Online Specialty Consultations

    The Partners Online Specialty Consultations (POSC) service allows physicians all over the world to refer cases to Dana-Farber oncologists for expert second opinions. This service is available only for adult patients.

    Partners Online Specialty Consultations can be initiated by a patient or physician. Patients requesting consultations need to involve their local physician, who registers with the service and completes a patient history.

    How to transfer a patient in an emergency

    We can help with the rapid transfer and transport of patients to our facilities. Our team will facilitate communication between you and receiving physicians, locate inpatient beds, and arrange transport.

    For adult patients, call 877-637-3337 and press "2" for Brigham and Women's Hospital. Dana-Farber partners with Brigham and Women's Hospital for adult care.

    For pediatric patients, call 866-771-KIDS (5437). Dana-Farber collaborates with Boston Children's Hospital to provide inpatient care for children.

    Physician liaisons

    Physician liaisons are available to assist you with patient referrals, consultations with specialists, and background information about our physicians and services. For adult care, call 617-632-2060. For pediatric care, call 617-919-3002.

    Information for insurance professionals

    Dana-Farber Cancer Institute and Brigham and Women's Hospital have been designated Centers of Excellence by the nation's leading insurance providers. We are eager to assist you in providing quality care to your clients.

    Managed care inquiries

    Diane P. Lanahan, MBA, RN
    617-632-5074

    Oncology and stem cell transplant referrals

    877-332-4294

    Financial counseling and support services

    617-632-3730

    Request a speaker

    Oncology specialists from Dana-Farber/Brigham and Women's Cancer Center are available to offer clinical updates to your organization. To arrange a speaker for your conference or meeting, please call 617-632-2060, and one of our physician liaisons will assist you.

  • Additional Resources

    Clinical Trials for Breast Cancer Patients

    Dana-Farber trials include for immunotherapy and targeted treatments for hormone receptor positive, HER2-positive, and triple-negative breast cancer. Many of our trials are changing the standard of care worldwide and are not available elsewhere.

    Hematologic Malignancies Resources

    We collaborate with our referring providers to ensure that our shared patients have access to care and needed services, in the most convenient location for them during treatment. Partnering with you, we help your patients receive their care closer to home -- reducing the time and cost of care without sacrificing quality.

    Stem Cell Transplant Resources for Providers and Payers

    The Adult Stem Cell Transplantation Program at Dana-Farber/Brigham and Women’s Cancer Center is one of the largest and most experienced stem cell transplant programs in the world. We work closely with providers and payers from throughout the region, across the nation, and around the world. We look forward to collaborating with you.

    Advances in Hematologic Malignancies eNewsletter

    Our biannual eNewsletter keeps clinicians the world over abreast of the latest advances from Dana-Farber/Brigham and Women’s Cancer Center -- in hematologic oncology research and care, current clinical trials, and upcoming CME programs.

    Physician Gateway

    Our physician portal helps you keep track of patients you have referred to Dana-Farber/Brigham and Women's Cancer Center for care. Physician Gateway is available for primary care providers, referring providers, and your authorized office staff.

    Clinical Affiliations and Collaborations

    Our affiliations and collaborations with hospitals and research institutions provide our patients with the finest cancer care possible, and provide physicians and insurers with a streamlined referral system.